IDEAYA Biosciences, Inc. (IDYA) Financials

IDYA Assets vs Liabilities
DateAssetsLiabilities
March 31, 2026 1.0 billion 93.1 million
Dec. 31, 2025 1.1 billion 86.4 million
Sept. 30, 2025 1.2 billion 93.1 million
June 30, 2025 1.0 billion 81.6 million

IDYA Free Cash Flow and Stock based compensation
Graph available only for paid members. Upgrade to see it.
DateFree Cash FlowStock based compensation
March 31, 2026 -76.1 million ?
Dec. 31, 2025 -90.8 million 11.8 million
Sept. 30, 2025 142.2 million 12.2 million
June 30, 2025 -63.1 million 11.9 million

IDYA Net Income

No data available :(

IDYA Cash and Debt
Graph available only for paid members. Upgrade to see it.
DateCashDebtCapital Lease
March 31, 2026 671.2 million 28.3 million -
Dec. 31, 2025 639.4 million 27.6 million 27.6 million
Sept. 30, 2025 786.9 million - 27.2 million
June 30, 2025 669.7 million - 26.6 million

IDYA Shares Outstanding
Graph available only for paid members. Upgrade to see it.
DateShares Outstanding
March 31, 2026 88.7 million
Dec. 31, 2025 88.6 million
Sept. 30, 2025 89.7 million
June 30, 2025 88.5 million

IDYA Expenses
Graph available only for paid members. Upgrade to see it.
DateCapexR&DG&AS&M
March 31, 2026 967000 95.7 million 19.4 million -
Dec. 31, 2025 333000 86.6 million 18.8 million -
Sept. 30, 2025 42000 83.0 million 16.4 million -
June 30, 2025 663000 74.2 million 14.6 million -

IDYA Cost of Revenue
Graph available only for paid members. Upgrade to see it.
DateRevenueCost of Revenue
March 31, 2026 6.6 million 1.1 million
Dec. 31, 2025 10.9 million 1.2 million
Sept. 30, 2025 207.8 million 1.0 million
June 30, 2025 - 1.2 million

IDYA Revenue by Segment
Graph available only for paid members. Upgrade to see it.

IDYA

Price: $30.23

52 week price:
20.46
39.28

Earnings Per Share: -1.57 USD

Exchange: NMS

Sector: Healthcare

Industry: Biotechnology

Country: United States

Volume: 546053

Market Capitalization: 2.4 billion

Links: